Kocostar Face Therapy Acne Treatment Cream to Patch

Description

The product is a cream formulation identified by SPL code 34089-3. It contains an active ingredient, the specifics of which are not provided. The cream is packaged in a carton and includes various inactive ingredients, details of which are also not specified. The physical appearance of the cream is characterized by attributes that are not detailed in the provided information.

Uses and Indications

This drug is indicated for the treatment of acne. It effectively clears acne blemishes and facilitates the healing of the skin. Additionally, it helps prevent the formation of new acne blemishes.

There are no teratogenic or nonteratogenic effects mentioned associated with this drug.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The product must be shaken well before use. A thin layer should be applied to the entire affected area using a sterile cotton swab. After application, the area should be allowed to dry completely, and the product should remain in place for a duration of 8 hours to facilitate healing.

To remove the product, the area should be moistened with warm water, and the product can be gently rolled off using the fingertips.

Initial treatment should consist of one application daily. Depending on the patient's response and as directed by a physician, the frequency may be gradually increased to two or three times daily. In cases where excessive dryness or peeling occurs, it is advisable to reduce the application frequency to once daily or every other day.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

For external use only. This product is contraindicated for application on broken skin or large areas of the skin. Caution is advised when using this product in conjunction with other topical acne medications, as the likelihood of skin irritation and dryness may increase. In the event of irritation, it is recommended to discontinue use of all topical acne medications and utilize only one at a time.

Healthcare professionals should instruct patients to cease use and consult a physician if irritation becomes severe. Additionally, it is imperative to avoid contact with the eyes; should contact occur, the affected area must be flushed thoroughly with water. In cases of ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only and should not be applied to broken skin or large areas of the skin. The use of this medication in conjunction with other topical acne treatments may increase the likelihood of skin irritation and dryness.

In the event that irritation becomes severe, patients are advised to discontinue use and consult a healthcare professional. Additionally, care should be taken to avoid contact with the eyes; should contact occur, it is recommended to flush the eyes thoroughly with water.

Drug Interactions

The concurrent use of this product with other topical acne medications may increase the risk of skin irritation and dryness. To minimize the potential for adverse effects, it is advised that only one topical acne medication be used at a time. If skin irritation occurs, discontinuation of one of the topical agents should be considered to alleviate symptoms. Monitoring for signs of irritation is recommended during the use of multiple topical treatments.

Packaging & NDC

Below are the non-prescription pack sizes of Kocostar Face Therapy Acne Treatment Cream to Patch (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of this product during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus, including the risk of teratogenic effects associated with its use. Therefore, pregnant women should avoid using this product and consult a healthcare provider for alternative acne treatments. It is essential for healthcare professionals to consider these factors when advising women of childbearing potential regarding the use of this product during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants during the use of this product.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data regarding its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution when administering the medication. It is essential to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should implement supportive measures as necessary, which may include symptomatic treatment and monitoring of vital signs.

Due to the lack of detailed overdosage information, it is recommended that healthcare professionals refer to established clinical guidelines and protocols for managing overdose situations relevant to the specific medication in question. Additionally, contacting a poison control center may provide further guidance on appropriate management strategies.

Continued vigilance and patient assessment are crucial in mitigating potential risks associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients that in the event of accidental ingestion, it is crucial to seek medical assistance immediately or contact the Poison Control Center. This information is vital for ensuring patient safety and prompt intervention in case of an emergency.

Storage and Handling

The product is supplied in various configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature, ensuring that it is kept away from heat sources and direct sunlight to maintain its integrity.

To preserve the quality of the product, lids must be kept tightly closed when not in use. Additionally, it is important to avoid dipping used cotton swabs into the essence to prevent contamination. Proper handling and storage practices are crucial for ensuring the product remains effective and safe for use.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Kocostar Face Therapy Acne Treatment Cream to Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)